Prolonged duration of gonadotropin inhibition by a third generation gnrh antagonist

Journal of Clinical Endocrinology and Metabolism

Volumn 67, Issue 6, 1988, Pages 1325-1327

  Leal, Juan A ^a   Williams, Robert F ^a   Danforth, Douglas R ^a   Gordon, Keith ^a   Hodgen, Gary D ^a  

^a The Jones Institute for Reproductive Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN ANTAGONIST; GONADOTROPIN;

ANIMAL EXPERIMENT; BIOASSAY; DOSE RESPONSE; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE INHIBITION; INTRAVENOUS DRUG ADMINISTRATION; LUTEINIZING HORMONE BLOOD LEVEL; MONKEY; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLICLE STIMULATING HORMONE; GONADORELIN; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; LUTEINIZING HORMONE; MACACA FASCICULARIS; OLIGOPEPTIDES; OVARIECTOMY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0024246518     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-67-6-1325     Document Type: Article

References (14)

1. Coy DH, Horvath A, Nekola MV, Coy EJ, Erchegyi J, Schally AV 1982 Peptide antagonists of LH-RH: Large increases in antiovulatory activities produced by basic D-amino acids in the six position. Endocrinology 110:1445
2. Kenigsberg D, Littman BA, Hodgen GD 1984 Medical hypophysectomy I: Dose-response using a GnRH antagonist. Fertil Steril 42:112
3. Kenigsberg D, Hodgen GD 1984 Medical hypophysectomy II: Variability of ovarian response to gonadotropin therapy. Fertil Steril 42:116
4. Nestor JJ Jr, Tahilramani R, Ho TL, McRae GI, Vickery BH, Bremmer WJ 1983 New luteinizing hormone-releasing factor antagonists. In Hruby VJ, Rich DH (eds) Peptides: Structure and Function, Pierce Chemical Company, Rockford, Illinois, p 861
5. 6) -LHRH, A potent antagonist of LHRH, produces transient edema and behavioral changes in rats. Contraception 29:283
6. Karten MJ, Hook WA, Siraganian RP, Coy DH, Folkers K, Rivier JE, Roeske RW 1987 In vitro histamine release with LHRH analogs. In Vickery B, Nestor J, Jr. (eds) LHRH and its Analogs, Part 2. MTP Press, Boston, p 179
7. Roeske R, Chaturvedi N, Hrinyo-Pavlina T, Kowalczuk M 1987 LHRH antagonists with low histamine release activity. In Vickery B, Nestor J, Jr. (eds) LHRH and its Analogs, Part 2. MTP Press, Boston, p 17
8. Pavlou SN, Wakefield GB, Island DP, Hoffman PG, LePage ME, Chan RL, Nerenberg CA, Kovacs WJ 1987 Suppressional pituitary gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men. J Clin Endoc Metab 64:931
9. Rivier J, Porter J, Rivier C, Perrin M, Corrigan A, Hook W, Siraganian R, Vale W 1986 New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro. J Med Chem 29:1846
10. Folkers K, Bowers C, Tang P, Feng D, Okamoto T, Zhang Y, Ljungqvist A 1987 Specificity of design to achieve antagonists of LHRH of increasing effectiveness in therapeutic activity. In Vickery B, Nestor J, Jr. (eds) LHRH and its Analogs, Part 2. MTP Press, Boston, p 25
11. Goodman AL, Nixon WE, Johnson DK, Hodgen GD 1977 Regulation of folliculogenesis in the cycling rhesus monkey: Selection of the dominant follicle. Endocrinology 100:155
12. Hodgen GD, Tullner WW, Vaitukaitis JL, Ward DN, Ross GT 1974 Specific radioimmunoassay of chorionic gonadotropin during implantation in rhesus monkeys. J Clin Endocrinol Metab 39:457
13. VanDamme MP, Robertson DM, Diczfalusy E 1979 An improved in vitro bioassay method for measuring luteinizing hormone (LH) activity using mouse Leydig cell preparations. Acta Endocrinologica 77:655
14. Kirk RE 1968 Experimental Design: Procedures for the behavioral Sciences. Brooks/Cole Publishing Co., Belmont, Ca.